ArticleHaematologica2018

Comment on "MEK inhibition with trametinib and tyrosine kinase inhibition with imatinib in multifocal histiocytic sarcoma".

Sophie Voruz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.